Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers

Launched by CLINICAL LASERTHERMIA SYSTEMS AB · Feb 19, 2016

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Are male or female \> 18 years of age
• • Have histologically confirmed, locally uncontrolled, solid cancer, with or without metastases, that cannot be treated surgically due to unresectability or inoperability
• • Have one or more tumours assessable by MRI/CT or ultrasound and situated in such a way that at least a part of the tumour can be treated with IMILT without damage to surrounding vital structures or the skin
• • Are candidates for ablative intervention also outside this study
• • Have given informed verbal and written consent to participation in the trial
• • Have an ECOG performance status \< 2 (Karnofsky \> 60%)
• • Have stable haematologic, renal and hepatic functions
• Exclusion Criteria:
• • Are HIV positive
• • Have an active autoimmune disease
• • Are on systemic corticosteroid medication (local treatment with aerosol's and ointment is allowed)
• • Have known bleeding disorders or are treated with anticoagulant medication
• • Are pregnant or nursing